Abstract
Additive effect of combined treatment with the small peptide GH receptor antagonist, AZP-3813, and the somatostatin analog, octreotide, in decreasing IGF1 levels in the rat
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have